International Lung Cancer Summit
@lungsummit
An interactive conference for thoracic experts to discuss recent advances in the treatment of #LungCancer. Bridging the gap in thoracic oncology together.
ID: 1088112289310523398
http://www.lungcancersummit.org 23-01-2019 16:32:40
2,2K Tweet
2,2K Followers
1,1K Following
You can join us at the #ILCS24 onsite in the beautiful city of Lausanne or virtually online! If you're joining us in person, you can find us at the CHUV / Centre hospitalier universitaire vaudois on October 4th, 2024, from 10AM CET. We look forward to seeing you there 👋
International Lung Cancer Summit Her 16 kişiden 1'i yaşamı boyunca akciğer kanseri tanısı alıyor.
Survivorship in Lung Cancer, a great theme to usher in a new era in thoracic oncology Join LUNGevity Foundation on Sept 20-21! excited to join inspiring speakers Solange Peters Stephen V Liu, MD Suresh S. Ramalingam, MD, FASCO & more Beaumont RCSI Cancer Centre CancerTrialsIreland 🌈 #IrishLungCancerCommunity #IrishLungCancerAlliance
Join Jarushka Naidoo, live in the beautiful city of Lausanne or online, to explore the role of #ADCs in lung cancer treatment at the upcoming #ILCS24! 🗓️ 4th October from 10AM CET Secure your seat and get involved in the discussion with leading experts ⬇️
How much tissue do we need for pathological testing for early #LungCancer? 🫁 Hear insights from Lukas Bubendorf, plus much more on tissue acquisition, thoracic surgery, and targeted therapies with Isabelle Opitz, Carolin Steinack, Brendon Stiles and Martin Reck ⬇️
The FDA Oncology has recently approved new treatments for #NSCLC including durvalumab with chemotherapy as well as lazertinib in combination with amivantamab-vmjw 🫁 Read more about the approvals ⬇️
What is the current therapeutic landscape for #LungCancer with KRAS, HER2, and C-MET alterations? Explore the topic with Biagio Ricciuti, MD PhD at the upcoming #ILCS24, live in Lausanne or virtually! 🗓️ 4th Oct 2024, from 10AM CET Register and get involved in the discussion ⬇️
Should we take every opportunity to cease immunotherapy for advanced #NSCLC to balance efficacy, toxicity and patient-centered care? Join Giannis Mountzios to explore this question at the #ILCS24, and share your insights! ⏰ 4th Oct, from 10AM CET Register your seat now ⬇️
How do we assess #HER2 in immunohistochemistry for lung and lower gastrointestinal cancers? An important question for indications which don't yet have clear guidelines. Explore the question plus much more with Ilaria Colombo, Florian Lordick, and Hochmair Maximilian ⬇️
🚨 The #ILCS24 is just ONE MONTH away! Connect with global experts, live in Lausanne or online, to explore the latest discoveries and therapeutic advances in thoracic oncology, alongside Solange Peters and Alfredo Addeo MD as your hosts! Have you secured your spot? Register now ⬇️